MedPath

A CLINICAL TRIAL OF MURCHHITA GO GHRITA AND SHATAVARI GHRITA IN INTERNAL OLEATION THERAPY IN HYPER-ACIDITY.

Phase 2
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitisHealth Condition 2: K296- Other gastritis
Registration Number
CTRI/2020/12/030099
Lead Sponsor
PARUL INSTITUTE OF AYURVED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients indicated for Snehapana.

2) Age group between 18-60 years.

3) Patient having the classical sign & symptoms of Urdhwaga Amlapitta

4)Patien t indicated for Vaman

Exclusion Criteria

1) Patients contraindicated for Snehapana and Vamana.

2) Urdhwaga Amlapitta associated with other systemic disorder-Diabetes mellitus, Hypertension, Carcinoma, Tuberculosis, Infectious diseases, Pregnant Women and other life threatening disorders.

3) Known Patients of Gastric or Duodenal ulcer or with its complications, Gastric Carcinoma will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath